576th Roundtable for Entrepreneurs Starting NOW: Live Tweeting by @1Mby1M

Today’s 576th FREE online 1Mby1M Roundtable For Entrepreneurs is starting NOW, on Thursday, May 26, at 8 a.m. PDT/11 a.m. EDT/5 p.m. CEST/8:30 p.m. India IST. CLICK HERE to join. PASSWORD: startup  All are welcome!

Featured Videos

576th Roundtable for Entrepreneurs Starting in 30 Minutes: Live Tweeting by @1Mby1M

Today’s 576th FREE online 1Mby1M Roundtable for Entrepreneurs is starting in 30 minutes, on Thursday, May 26, at 8 a.m. PDT/11 a.m. EDT/5 p.m. CEST/8:30 p.m. India IST. CLICK HERE to join. PASSWORD: startup  All are welcome!

Alteryx Builds on Trifacta Acquisition to Target Enterprise Sales

According to an IDC report, the global data analytics market is expected to grow from $65 billion this year to over $110 billion by 2025. Data science and analytics platform provider Alteryx’s (NYSE: AYX) recently announced impressive quarterly results. The company Is stepping up its focused sales approach to drive the adoption of its products within the larger enterprise segment.

Video FAQs

Thought Leaders in Artificial Intelligence: Starmind CEO Marc Vontobel (Part 4)

Sramana Mitra: Bottomline is, you’re talking about narrowing the market down more and more to figure out where you want to penetrate the market and where you really want to build the business. Then there are sales channel issues. You have to put Salesforce going after each other’s markets. Let’s get to the technology side of what you’re doing. What datasets are you working with? Let’s take the pharma use case.

Marc Vontobel: There’s always a certain set of tools focused on the use case itself. In R&D, for example, we often see some kind of application that manages the new patterns that people are working on. That’s a very good source for us to learn.

Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 2)

Sramana Mitra: What is the dataset? Across all these categories, how many drugs and treatments are we talking about that you have modeled and have data for?

Sungwon Lim: Our first service which we commercialized last year is for dog blood cancer. What we are trying to do is help doctors make decisions. The 16 drugs that are used for lymphoma and leukemia are being tested on our platform. We collect the real-world actual treatment cases and provide our reports today.

Best of Bootstrapping: Bootstrapping with Sophisticated Strategic Maneuvering

If you haven’t already, please study our Bootstrapping Course and Investor Introductions page. 

BioConnect Founder CEO Rob Douglas has built a thriving founder-financed business from Toronto using very sophisticated strategic maneuvering. I just loved discussing the strategic nuances of this business. You’ll learn a LOT from reading this story.

Sramana Mitra: Let’s start at the very beginning of your journey. Where are you from? Where were you born, raised, and in what kind of background?

Rob Douglas: I’m a Canadian. I was born just outside of Toronto. I have grown up in and around the city of Toronto. I’m married. I have two kids. Both of them are in their 20’s. I have spent most of my entrepreneurial life primarily focused on markets outside of Canada. US and EMEA have been primary markets over my career.

>>>

Cloud Stocks: Dynatrace Targets $50B Addressable Market

The global market for Application Performance Management (APM) is estimated to grow at over 11% CAGR to reach $11.9 billion by 2027. Dynatrace (NYSE: DT), a market leader in this industry, recently reported its quarterly results that outpaced market expectations.

Thought Leaders in Artificial Intelligence: Starmind CEO Marc Vontobel (Part 3)

Marc Vontobel: Without having very good positioning, we already created traction and signed some big deals with some Fortune 500 companies. That helped us find out the real use cases where we can have a real impact on the business. If you buy Starmind without having a clear use case in mind, you always depend on the vision of the buyer. We have found a few of those, but it’s not repeatable.

Sramana Mitra: That’s a very rare buyer who can take a technology and find an application for it. That’s not the way to build a company at all.